For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251217:nRSQ7907La&default-theme=true
RNS Number : 7907L Derwent London PLC 17 December 2025
Derwent London plc ("Derwent London" / "the Group")
Planning success at Blue Star House SW9
Derwent London is pleased to announce that, as part of its ongoing strategy to
optimise values across the portfolio, it has received resolution to grant
planning permission for a hotel-led scheme at Blue Star House, Brixton SW9.
Designed by GRID Architects, the 341-room hotel development, which is opposite
the O2 Academy Brixton, has a total net lettable area of 86,100 sq ft, a 60%
uplift from the current floorspace. In addition to the hotel, there will be
ground floor office/commercial space and public realm improvements. The
refurbishment and extension of the existing eleven-storey building is in line
with our sustainable, carbon efficient approach to regeneration. Works are
expected to commence in mid-2027 with completion in late 2029.
Paul Williams, Chief Executive of Derwent London, said:
"Securing unanimous approval for this hotel-led conversion in Brixton is an
important milestone on our journey to maximise value at Blue Star House. The
scheme is well-located in the heart of the community and will support further
local regeneration."
For further information, please contact:
Derwent London Paul Williams, Chief Executive
Tel: +44 (0)20 3478 4217 (Robert Duncan) Jonathan Theobald, Head of Investment Analytics
Robert Duncan, Head of Investor Relations
Brunswick Group Nina Coad
Tel: +44 (0)20 7404 5959 Peter Hesse
Notes to editors
Derwent London plc
Derwent London plc owns a commercial real estate portfolio predominantly in
central London valued at £5.2 billion as at 30 June 2025, making it the
largest London office-focused real estate investment trust (REIT).
Our experienced team has a long track record of creating value throughout the
property cycle by regenerating our buildings via redevelopment or
refurbishment, effective asset management and capital recycling. We typically
acquire central London properties off-market with low capital values and
modest rents in improving locations, most of which are either in the West End
or City Borders. We capitalise on the unique qualities of each of our
properties - taking a fresh approach to the regeneration of every building
with a focus on anticipating tenant requirements and an emphasis on design.
Reflecting and supporting our long-term success, the business has a strong
balance sheet with modest leverage, a robust income stream and flexible
financing.
We are frequently recognised in industry awards for the quality, design and
innovation of our projects. Landmark buildings in our 5.3 million sq ft
portfolio include 25 Baker Street W1, 1 Soho Place W1, 80 Charlotte Street W1,
Brunel Building W2, White Collar Factory EC1, Angel Building EC1 and Tea
Building E1.
As part of our commitment to lead the industry in mitigating climate change,
Derwent London has committed to becoming a net zero carbon business by 2030,
publishing its pathway to achieving this goal in 2020. Our science-based
carbon targets have been validated by the Science Based Targets initiative
(SBTi). In 2013, we launched a voluntary Community Fund which to date has
supported 180 community projects in central London.
The Company is a public limited company, which is listed on the London Stock
Exchange and incorporated and domiciled in the UK. The address of its
registered office is 25 Savile Row, London, W1S 2ER.
For further information see www.derwentlondon.com
(http://www.derwentlondon.com) or follow us on LinkedIn.
Forward-looking statements
This document contains certain forward-looking statements about the future
outlook of Derwent London. By their nature, any statements about future
outlook involve risk and uncertainty because they relate to events and depend
on circumstances that may or may not occur in the future. Actual results,
performance or outcomes may differ materially from any results, performance or
outcomes expressed or implied by such forward-looking statements.
No representation or warranty is given in relation to any forward-looking
statements made by Derwent London, including as to their completeness or
accuracy. Derwent London does not undertake to update any forward-looking
statements whether as a result of new information, future events or otherwise.
Nothing in this announcement should be construed as a profit forecast.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END MSCDZMMZMVDGKZM
Copyright 2019 Regulatory News Service, all rights reserved